• Report Preview
  • Report Description
  • Table Of Content
  • Request Methodology

High Prevalence and Incidence Rates of diseases are Likely to Drive the Global Pharmaceutical Intermediates Market at 6.1% CAGR During 2019 & 2024.

Global pharmaceutical intermediates market accounted for USD 27,356.1 million in 2018 and is estimated to reach USD 38,457.2 million in 2024, registering a compound annual growth rate (CAGR) of 6.1% between 2019 and 2024.

Rising Production of APIs

Increasing production of active pharmaceutical ingredients is accelerating the demand for pharmaceutical intermediates. Further, increasing trend towards new high-tech therapeutics coupled with the development of innovative delivery systems and innovation in personalized medicine is believed to further emphasize the growing demand for the active pharmaceutical market. This bodes well for global pharmaceutical intermediates market. Due to the rise in the demand for quality APIs, there is growing investment in research & development for API production which will result in increased demand for pharmaceutical intermediates.

Launch of Innovative Pharmaceutical Intermediates

Pharmaceutical intermediates manufacturers are investing heavily in the development of new intermediates. The market is also expected to significantly benefit from this. In addition, patent expiry is also supposed to positively impact the growth of the global pharmaceutical intermediate market. Apart from this, continuous demand for new and innovative therapies are offering promising growth of pharmaceutical intermediates market over the forecast period.

Increasing Prevalence of Diseases

Rising prevalence of various infectious and chronic diseases is resulting in increased demand for pharmaceuticals which, in turn, is spearheading current and future growth of pharmaceutical intermediates market. According to the CDC (Centers for Disease Control and Prevention), there were around 16.8 million physician visits for infectious and parasitic diseases in the United States. Further, supportive government healthcare initiatives are believed to garner the growth of the market in the years ahead.

Barriers in Market

The pharmaceutical industry comprises of a large pool of small, medium & giant manufacturers of pharmaceutical intermediates. Apart from this, the number of contract manufacturing organizations are also increasing especially in the Asia Pacific region which has also increased market competition across the globe. Regulatory requirements are tightening and will likely continue to do so with a push for more transparency in the supply chain in the future. These increasing regulatory related issues have brought difficulties for pharmaceutical intermediate suppliers across the globe. The prices of intermediates are moving up as regulatory-related expenses such as fees related to the Generic Drug User Fee Act in the U.S. Are increasing. This unstable pricing trend is adversely affecting the supplying network of the intermediates. Most of the demand for pharmaceutical intermediate is largely derived from the demand for drug manufacturers' products. This factor subjects pharmaceutical intermediate manufacturers to uncertainties related to downturns in their customers.

Frequently Asked Questions

What is the value of Pharmaceutical Intermediates Market in 2019?

The Pharmaceutical Intermediates Market accounted for USD 27,356.1 million in 2019.

What will be the Pharmaceutical Intermediates Market worth in the terms of value in 2024?

In 2024, the Pharmaceutical Intermediates Market is anticipated to reach to a market valuation of USD 38,457.2 million.

What is expected compound annual growth rate (CAGR) at which market is anticipated to flourish during the forecast period?

The Pharmaceutical Intermediates Market is expected to grow at a compound annual growth rate (CAGR) of 6.1% during the forecast period.

What are key factors driving the growth of Pharmaceutical Intermediates Market?

Increasing production of active pharmaceutical ingredients is accelerating the demand for pharmaceutical intermediates. Further, increasing trend towards new high-tech therapeutics coupled with the development of innovative delivery systems and innovation in personalized medicine is believed to further emphasize the growing demand for the active pharmaceutical market.

What does this report offer?

The report offers a comprehensive insight on the Pharmaceutical Intermediates Market share, competitor landscape, market trends, growth, revenue, and key driver’s analysis with coverage of key players, top geographies and End-User.

What research methodology is used to write this market research report?

Exhaustive secondary research and in-depth primary interviews with industry experts has been conducted to present qualitative and quantitative insights in the report.

What else can be covered in the scope of this report?

We offer customizations as per client’s specific needs.

Global pharmaceuticals intermediates market is expected to reach USD 38,457.2 Million by the end of 2024 from USD 27,356.1 Million in 2018. The market of global pharmaceuticals intermediates will be receiving an opportunity of USD 9,845.4 Million between 2019 & 2024. In addition to this, global pharmaceuticals intermediates market value is projected to witness a Y-O-Y growth of 7.3% in 2024 as compared to previous years. Further, the market value of global pharmaceuticals intermediates market is expected to rise at a CAGR of 6.1% over the projected period.

The world pharmaceutical intermediates are segmented by end-user into four:  pharmaceutical companies, research labs, contract manufacturing organizations, and others. With a market share of 76.4%, pharmaceutical companies market captured the major portion of the market. According to KDMI, in the end-user segment, the pharmaceuticals company market is expected to be the most attractive market in the global pharmaceutical intermediates market over the forecast period. Further, this market is projected to open new avenues for the market players and to be the most lucrative market over the forecast period. Apart from this, when compared with other segments, the research labs market is anticipated to attain the highest CAGR over the upcoming years i.e. 2019-2024.

In terms of geography, the pharmaceutical intermediates market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Pharmaceutical intermediates market in China was held at USD 6,685.1 Million in 2018 and is presenting a lucrative growth opportunity for industry players. At projected CAGR China will be one of the fastest growing pharmaceutical intermediates market in the years ahead.  United States market for pharmaceutical intermediates is expected to increase from USD 5,599.8 Million in 2018 to a notable revenue by 2024. Between 2018 and 2024, it represents an incremental value opportunity of USD XXXX Million.

The key players profiled in the report include Aceto, Eastar, BASF SE, Midas Pharma, A.R. Life Sciences Pvt. Ltd., Lianhetech and other major key players. These market players have adopted different business strategies, such as acquisition, product launch, merger, and partnership to stay competitive in the global market. Pharmaceutical intermediates companies are expanding their businesses in terms of product offering and regional markets. This expansion trend is benefiting manufacturers by allowing them to deliver more advanced one-stop solutions to their customers. For instance, AGC Inc. has recently expanded its facilities at its Chiba Plant that resulted in an approximately tenfold increase in the company’s GMP1-compliant synthetic pharmaceutical intermediate and active ingredient2 production capacity.

Market Segmentation:

By End User
- Pharmaceutical Companies
- Research Labs
- Contract Manufacturing Organizations
- Others

Regional Markets
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa

Research Methodology
Market Definition and List of Abbreviations
1. Executive Summary
2. Growth Drivers & Issues in Global Pharmaceutical Intermediates Market
3. Global Pharmaceutical Intermediates Market Trends
4. Opportunities in Global Pharmaceutical Intermediates Market
5. Recent Product Type Activities, 2019
6. Porter's Five Forces Analysis
7. Market Value Chain and Supply Chain Analysis
8. Global Pharmaceutical Intermediates Market Value (USD Million), Growth Analysis and Forecast, (2017-2024)

9. Global Pharmaceutical Intermediates Market Segmentation Analysis, By Application
9.1. Introduction
9.2. Market Attractiveness, By Application
9.3. BPS Analysis, By Application
9.4.  Pharmaceutical Companies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
9.5.  Research Labs Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
9.6.  Contract Manufacturing Organizations Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
9.7.  Other Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024

10. Geographical Analysis
10.1. Introduction
10.2. North America Pharmaceutical Intermediates Market Value (USD Million) & Volume, 2017-2024
10.2.1. By Application
10.2.2. By Country
10.2.2.1. Market Attractiveness, By End-user
10.2.2.2. BPS Analysis, By End-User
10.2.2.3. U.S. Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.2.2.4. Canada Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024

10.3. Europe Pharmaceutical Intermediates Market Value (USD Million) & Volume, 2017-2024
10.3.1. By Application
10.3.2. By Country
10.3.2.1. Market Attractiveness, By Country
10.3.2.2. BPS Analysis, By Country
10.3.2.3. Germany Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.3.2.4. United Kingdom Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.3.2.5. France Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.3.2.6. Italy Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.3.2.7. Spain Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.3.2.8. Russia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.3.2.9. Rest of Europe Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024

10.4. Asia Pacific Pharmaceutical Intermediates Market Size (USD Million), 2017-2024
10.4.1. By Application
10.4.2. By Country
10.4.2.1. Market Attractiveness, By Country
10.4.2.2. BPS Analysis, By Country
10.4.2.3. China Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.4.2.4. India Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.4.2.5. Japan Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.4.2.6. South Korea Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.4.2.7. Indonesia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.4.2.8. Taiwan Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.4.2.9. Australia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.4.2.10. New Zealand Market Size (USD Million, 2017-2024
10.4.2.11. Rest of Asia Pacific Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024

10.5. Latin America Pharmaceutical Intermediates Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.5.1. By Application
10.5.2. By Country
10.5.2.1. Market Attractiveness, By Country
10.5.2.2. BPS Analysis, By Country
10.5.2.3. Brazil Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.5.2.4. Mexico Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.5.2.5. Rest of Latin America Market Size (USD Million, 2017-2024

10.6. Middle East & Africa Pharmaceutical Intermediates Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.6.1. By Application
10.6.2. By Geography
10.6.2.1. Market Attractiveness, By Geography
10.6.2.2. BPS Analysis, By Geography
10.6.2.3. GCC Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.6.2.4. North Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.6.2.5. South Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024
10.6.2.6. Rest of Middle East & Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2017-2024

11. Competitive Landscape
11.1. Market Share of Key Players
11.2. Market Positioning of Major Players in Global Pharmaceutical Intermediates Market
11.3. Company Profiles
11.3.1. Aceto
11.3.2. Eastar
11.3.3. BASF SE
11.3.4. Midas Pharma
11.3.5. A.R. Life Sciences Pvt. Ltd.
11.3.6. Lianhetech
11.3.7. Arkema
11.3.8. Hangzhou FST Pharmaceutical
11.3.9. Chemcon Specialty Chemical Pvt. Ltd.
11.3.10. Vertellus Holdings LLC
11.3.11. Other Major & Niche Key Players

Select License Type
  • Single User License $3750 USD
  • Multi-User License $4550 USD
  • Corporate User License $5500 USD

Request For Customization



Request Customization

Check Discount



Request Discount

Corporate Clients

More than 200 Clients